
Opinion|Videos|April 1, 2024
Paradigm Shift In Parkinson’s Disease Diagnosis
Author(s)Stuart H. Isaacson, MD, FAAN, Rajesh Pahwa, MD
The neurology experts discuss the importance of early and accurate diagnosis of Parkinson’s disease, the role of alpha-synuclein in the diagnosis of synucleinopathies and approaches to implementing screening protocols in clinical practice.
Advertisement
Episodes in this series
0:50 Diagnosis of Parkinson’s disease
3:20 Preclinical start of Parkinson’s disease
5:00 Alpha-synuclein in Parkinson’s disease
6:50 Biomarkers in Parkinson’s disease
12:00 Syn-One test for Parkinson’s disease
21:15 Advanced diagnostics in Parkinson’s disease
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
3
Using Human iPSC Models to Dissect PIRA Mechanisms in Progressive Multiple Sclerosis: Valentina Fossati, PhD
4
Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib
5











